DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma
Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to show if vaccination with autologous dendritic cells pulsed
with tumor lysate in combination with Cytokine-Induced Killer Cell (CIK) can induce a
measurable immune response in patients with renal cell carcinoma, and to evaluate the
clinical effect of the regimen.